Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer
Lifecore Biomedical announced two new contract development and manufacturing organization (CDMO) agreements with an existing U.S.-based biopharmaceutical customer. The agreements include a site transfer for manufacturing a currently marketed product and expansion of manufacturing to a second delivery system for an ophthalmic treatment. These deals …